शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

FABTECHNSEFabtech Technologies Limited· Healthcare Equipment & SuppliesHighNeutral
Announced Mon, 27 Oct, 2025 · 23:15 IST

Fabtech approves Q1 and Q2 FY26 results; Q1 revenue up 136%, loss of Rs 612.59 lakh

Revenue growth above 20%Results View source PDFExplain this filing

FABTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+9.7%Reaction day
₹229.01
prior close
₹240.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+9.4% vs market
Medical Equipment & Supplies peers, median of 12sector-0.1%+9.8% vs sector

On the reaction day the stock moved 9.4 pts more than Nifty Microcap 250 and 9.8 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.9
10m
-3.1
15m
-3.0
30m
-5.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+9.7+0.2+9.4-0.1+9.8
Next day
+4.9+0.7+4.2+2.8+2.1
2d
+2.2+0.5+1.7+2.9-0.7
3d
+1.1+0.1+0.9+0.6+0.5
4d
+3.5+1.2+2.3+0.3+3.2
5d
+3.4+0.4+3.0+1.7+1.7
1w
+6.5-0.9+7.4-0.3+6.9
15d
+3.9-1.1+5.1-4.8+8.7
1m
+4.8-2.7+7.4-8.8+13.5
2m
-12.9-6.3-6.5-10.8-2.1
3m
-28.7-11.7-17.0-17.6-11.1
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited June 2025 quarter and September 2025 quarter and half-year results. For the June quarter, consolidated revenue rose to Rs 6,800.68 lakh from Rs 2,875.01 lakh, but the group posted a net loss of Rs 612.59 lakh against profit of Rs 578.60 lakh last year. Standalone loss was Rs 916.04 lakh. An exceptional gain of Rs 177.49 lakh came from selling 51% of a subsidiary. The review report was unmodified.

Likely market impact

Strong revenue growth but a swing to loss; near-term earnings sentiment may stay weak, though the one-off stake sale added support.

By the numbersConsolidated · Q2 FY26
Q2 FY26Year agoChange
Revenue₹121.5 Cr——
Operating profit₹28.08 Cr——
Profit after tax₹28.11 Cr——
EBITDA margin25.1%——

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.